CVRX — CVRx, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-06-30.
Performance
Technicals
Others in Healthcare
Measured signals that fired on CVRX
| date | signal | measured base rate |
|---|---|---|
| 2026-06-11 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-03-19 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-13 | Binkowski Brent CHIEF OPERATING OFFICER | Open-market purchase | 26.2K | 2.91 | 76.4K |
| 2026-08-12 | Binkowski Brent CHIEF OPERATING OFFICER | Open-market sale 10b5-1 plan | 1.3K | 2.55 | 3.3K |
| 2026-06-01 | Nielsen Kirk G. Director | Grant or award | 8.7K | 0.00 | 0 |
| 2026-06-01 | DALE MICHAEL D Director | Grant or award | 29.0K | 0.00 | 0 |
| 2026-06-01 | Hill, Mitch C. Director | Grant or award | 8.7K | 0.00 | 0 |
| 2026-06-01 | Jain Mudit K. Director | Grant or award | 8.7K | 0.00 | 0 |
| 2026-06-01 | Ballinger Kevin J. Director | Grant or award | 8.7K | 0.00 | 0 |
| 2026-06-01 | SHADAN MARTHA Director | Grant or award | 8.7K | 0.00 | 0 |
| 2026-06-01 | SLATTERY JOSEPH P Director | Grant or award | 8.7K | 0.00 | 0 |
| 2026-03-02 | Hykes Kevin PRES & CEO | Open-market sale 10b5-1 plan | 7.8K | 7.90 | 61.3K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| JOHNSON & JOHNSON | 38.1M | 4.0M |
| NEA Management Company, LLC | 19.2M | 2.0M |
| BlackRock, Inc. | 9.7M | 1.0M |
| GSK plc | 9.5M | 1.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.6M | 911.3K |
| ROYAL BANK OF CANADA | 6.7M | 707.0K |
| Balyasny Asset Management L.P. | 6.0M | 630.8K |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 5.4M | 572.0K |
| Parkman Healthcare Partners LLC | 4.1M | 429.5K |
| GEODE CAPITAL MANAGEMENT, LLC | 4.0M | 427.1K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop · 2026-08-19
- HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop · 2026-08-14
- Cvrx, Inc. (CVRX) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about CVRX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →